Hige, Shuhei

Publishing since 2001 (Junior)

Has published 25 publications in 9 years

Number of publications published per year by Hige, Shuhei. (Source : PubMed)

Distribution of publications types for Hige, Shuhei. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, Ito Y, Mita E, Tanaka E, Mochida S, Murawaki Y, Honda M, Sakai A, Hiasa Y, Nishiguchi S, Koike A, Sakaida I, Imamura M, Ito K, Yano K, Masaki N, Sugauchi F, Izumi N, Tokunaga K, Mizokami M. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.  Nat. Genet.  2009;41;10  
•  Yotsuyanagi H, Kikuchi Y, Tsukada K, Nishida K, Kato M, Sakai H, Takamatsu J, Hige S, Chayama K, Moriya K, Koike K. Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis.  Hepatol. Res.  2009;39;7  
•  Iwasaki Y, Shiratori Y, Hige S, Nishiguchi S, Takagi H, Onji M, Yoshida H, Izumi N, Kohgo Y, Yamamoto K, Sato N, Shibuya A, Saito H, Sata M, Suzuki K, Kaneko S, Moriyama M, Omata M. A randomized trial of 24 versus 48 weeks of peginterferon alpha-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan.  Hepatology international  2009  
•  Ogawa K, Hige S, Nakanishi M, Yamamoto Y, Chuma M, Nagasaka A, Asaka M. Immunological and mutagenic actions of ribavirin monotherapy preceding combination therapy with interferon for patients with chronic hepatitis C.  Antivir. Ther. (Lond.)  2009;14;4  
•  Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, Yamamoto Y, Nakanishi M, Kohara T, Sho T, Yamamoto K, Horimoto H, Kobayashi T, Yokoo H, Matsushita M, Todo S, Asaka M. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.  J. Gastroenterol.  2009;44;9  
•  Chuma M, Hige S, Nakanishi M, Ogawa K, Natsuizaka M, Yamamoto Y, Asaka M. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.  J. Gastroenterol. Hepatol.  2008;23;9  
•  Nakanishi M, Chuma M, Hige S, Asaka M. Abscopal effect on hepatocellular carcinoma.  Am. J. Gastroenterol.  2008;103;5  
•  Miyazaki A, Hige S, Asahina Y, Oide H, Ogawa S. [Chronic viral hepatitis: a discussion]  Nippon Naika Gakkai Zasshi  2008;97;1  
•  Fujiwara K, Kaneko S, Kakumu S, Sata M, Hige S, Tomita E, Mochida S. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.  Hepatol. Res.  2007;37;9  
•  Kato M, Asaka M, Ono S, Nakagawa M, Nakagawa S, Shimizu Y, Chuma M, Kawakami H, Komatsu Y, Hige S, Takeda H. Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection.  J. Gastroenterol.  2007;42 Suppl 17  

[ See timeline ] [ See all publications ]